Matches in SemOpenAlex for { <https://semopenalex.org/work/W1666298349> ?p ?o ?g. }
- W1666298349 abstract "Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.To evaluate the effects of drugs for agitation and/or aggression following acquired brain injury (ABI).We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and other electronic databases. We also searched the reference lists of included studies and recent reviews. In addition we handsearched the journals Brain Injury and the Journal of Head Trauma Rehabilitation. There were no language restrictions. The searches were last updated in June 2006.Randomised controlled trials (RCTs) that evaluated the efficacy of drugs acting on the central nervous system for agitation and/or aggression, secondary to ABI, in participants over 10 years of age.We independently extracted data and assessed trial quality. Studies of patients within six months after brain injury and/or in a confusional state, were distinguished from those of patients more than six months post-injury, or who were not confused.Six RCTs were identified and included in this review. Four of theses evaluated the beta-blockers, propranolol and pindolol, one evaluated the central nervous system stimulant, methylphenidate and one evaluated amantadine, a drug normally used in parkinsonism and related disorders. The best evidence of effectiveness in the management of agitation and/or aggression following ABI was for beta-blockers. Two RCTs found propranolol to be effective (one study early and one late after injury). However, these studies used relatively small numbers, have not been replicated, used large doses, and did not use a global outcome measure or long-term follow-up. Comparing early agitation to late aggression, there was no evidence for a differential drug response. Firm evidence that carbamazepine or valproate is effective in the management of agitation and/or aggression following ABI is lacking.Numerous drugs have been tried in the management of aggression in ABI but without firm evidence of their efficacy. It is therefore important to choose drugs with few side effects and to monitor their effect. Beta-blockers have the best evidence for efficacy and deserve more attention. The lack of evidence highlights the need for better evaluations of drugs for this important problem." @default.
- W1666298349 created "2016-06-24" @default.
- W1666298349 creator A5028927871 @default.
- W1666298349 creator A5078791685 @default.
- W1666298349 creator A5090047720 @default.
- W1666298349 date "2006-10-18" @default.
- W1666298349 modified "2023-10-05" @default.
- W1666298349 title "Pharmacological management for agitation and aggression in people with acquired brain injury" @default.
- W1666298349 cites W109795170 @default.
- W1666298349 cites W112352086 @default.
- W1666298349 cites W121136978 @default.
- W1666298349 cites W1630519539 @default.
- W1666298349 cites W169289805 @default.
- W1666298349 cites W1758155888 @default.
- W1666298349 cites W182725121 @default.
- W1666298349 cites W1967716932 @default.
- W1666298349 cites W1969271590 @default.
- W1666298349 cites W1969580646 @default.
- W1666298349 cites W1971789030 @default.
- W1666298349 cites W1972161141 @default.
- W1666298349 cites W1978733745 @default.
- W1666298349 cites W1986215651 @default.
- W1666298349 cites W1987127523 @default.
- W1666298349 cites W1988931044 @default.
- W1666298349 cites W1995876262 @default.
- W1666298349 cites W1997708148 @default.
- W1666298349 cites W1998748704 @default.
- W1666298349 cites W2000725783 @default.
- W1666298349 cites W2002501515 @default.
- W1666298349 cites W2003266511 @default.
- W1666298349 cites W2021655452 @default.
- W1666298349 cites W2028436168 @default.
- W1666298349 cites W2032256476 @default.
- W1666298349 cites W2032991755 @default.
- W1666298349 cites W2033812365 @default.
- W1666298349 cites W2042244803 @default.
- W1666298349 cites W2044443383 @default.
- W1666298349 cites W2048473588 @default.
- W1666298349 cites W2052262163 @default.
- W1666298349 cites W2052621814 @default.
- W1666298349 cites W2055039185 @default.
- W1666298349 cites W2058959684 @default.
- W1666298349 cites W2064839408 @default.
- W1666298349 cites W2065172102 @default.
- W1666298349 cites W2067791685 @default.
- W1666298349 cites W2071113624 @default.
- W1666298349 cites W2072897782 @default.
- W1666298349 cites W2076446720 @default.
- W1666298349 cites W2077388796 @default.
- W1666298349 cites W2079323119 @default.
- W1666298349 cites W2080816111 @default.
- W1666298349 cites W2082873275 @default.
- W1666298349 cites W2083612258 @default.
- W1666298349 cites W2085793664 @default.
- W1666298349 cites W2090989307 @default.
- W1666298349 cites W2091165711 @default.
- W1666298349 cites W2099657984 @default.
- W1666298349 cites W2103906457 @default.
- W1666298349 cites W2108140351 @default.
- W1666298349 cites W2110413198 @default.
- W1666298349 cites W2113465450 @default.
- W1666298349 cites W2114224394 @default.
- W1666298349 cites W2117134295 @default.
- W1666298349 cites W2130281953 @default.
- W1666298349 cites W2130323362 @default.
- W1666298349 cites W2133663910 @default.
- W1666298349 cites W2135181116 @default.
- W1666298349 cites W2140648495 @default.
- W1666298349 cites W2140873297 @default.
- W1666298349 cites W2146599657 @default.
- W1666298349 cites W2148499303 @default.
- W1666298349 cites W2153875514 @default.
- W1666298349 cites W2156065126 @default.
- W1666298349 cites W2159210845 @default.
- W1666298349 cites W2164055530 @default.
- W1666298349 cites W2164346310 @default.
- W1666298349 cites W2165740328 @default.
- W1666298349 cites W2171026237 @default.
- W1666298349 cites W2171917610 @default.
- W1666298349 cites W2172214328 @default.
- W1666298349 cites W2314352173 @default.
- W1666298349 cites W2405398183 @default.
- W1666298349 cites W2410447563 @default.
- W1666298349 cites W2414453576 @default.
- W1666298349 cites W2415557736 @default.
- W1666298349 cites W2466339889 @default.
- W1666298349 cites W4252608859 @default.
- W1666298349 cites W4300758294 @default.
- W1666298349 cites W45032874 @default.
- W1666298349 doi "https://doi.org/10.1002/14651858.cd003299.pub2" @default.
- W1666298349 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17054165" @default.
- W1666298349 hasPublicationYear "2006" @default.
- W1666298349 type Work @default.
- W1666298349 sameAs 1666298349 @default.
- W1666298349 citedByCount "110" @default.
- W1666298349 countsByYear W16662983492012 @default.
- W1666298349 countsByYear W16662983492013 @default.
- W1666298349 countsByYear W16662983492014 @default.
- W1666298349 countsByYear W16662983492015 @default.
- W1666298349 countsByYear W16662983492016 @default.